Company / Current Assets
AbCellera Biologics Inc. Current Assets History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$728.2M
FY2025
5-year range
$728.2M / $1.0B
FY2021-FY2025
Trend
-3.1%
vs FY2024
Sector context
#77 of 213
Health Care
What the data says
At $728M, AbCellera Biologics Inc.'s current assets ranks #77 of 213 in the Health Care sector. Current Assets has declined for 3 consecutive years, from $1.0B in FY2022 to $728M in FY2025.
Based on SEC 10-K filings.
$728M in FY2025 with a 5-year CAGR of -2.2%.
Declined from $872M to $728M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -10.8%
- 5-Year CAGR
- -2.2%
- 10-Year CAGR
- -
Sector benchmark
#77 of 213 in Health CareTop 36% of 213This company $728.2M Sector average $2.5B
▼
-71.1% below sector average
Key checks
Key Insights
- AbCellera Biologics Inc.'s current assets has declined for 3 consecutive years.
- 5-year CAGR of -2.2%, indicating a declining trend.
- In FY2025, current assets decreased 3.1% year-over-year.
- Ranks #77 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $728.2M | -3.1% |
| FY2024 | $751.4M | -13.8% |
| FY2023 | $872.0M | -15.0% |
| FY2022 | $1.0B | +10.3% |
| FY2021 | $929.8M | +14.3% |
| FY2020 | $813.3M | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026